These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26962268)

  • 21. Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.
    Franco R; Canela EI; Casado V; Ferre S
    Expert Opin Drug Discov; 2010 Apr; 5(4):391-403. PubMed ID: 22823089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies as Endogenous Modulators of GPCR Signaling.
    Skiba MA; Kruse AC
    Trends Pharmacol Sci; 2021 Mar; 42(3):135-150. PubMed ID: 33358695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Throughput Screening for Allosteric Modulators of GPCRs.
    Bertekap RL; Burford NT; Li Z; Alt A
    Methods Mol Biol; 2015; 1335():223-40. PubMed ID: 26260604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allosteric Modulators of the Class A G Protein Coupled Receptors.
    Tschammer N
    Adv Exp Med Biol; 2016; 917():185-207. PubMed ID: 27236557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators.
    Orgován Z; Ferenczy GG; Keserű GM
    Curr Top Med Chem; 2019; 19(19):1768-1781. PubMed ID: 31393248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of an "Allosteric Site-Impaired" M
    Moo EV; Sexton PM; Christopoulos A; Valant C
    Mol Pharmacol; 2018 Nov; 94(5):1298-1309. PubMed ID: 30213802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
    Lütjens R; Rocher JP
    Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple method to detect allostery in GPCR dimers.
    Goupil E; Laporte SA; Hébert TE
    Methods Cell Biol; 2013; 117():165-79. PubMed ID: 24143977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric modulators of human A2B adenosine receptor.
    Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
    Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric modulators of cannabinoid receptor 1: developing compounds for improved specificity.
    Dopart R; Lu D; Lichtman AH; Kendall DA
    Drug Metab Rev; 2018 Feb; 50(1):3-13. PubMed ID: 29355030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research progress of indole-fused derivatives as allosteric modulators: Opportunities for drug development.
    Luo ML; Zhao Q; He XH; Xie X; Zhu HP; You FM; Peng C; Zhan G; Huang W
    Biomed Pharmacother; 2023 Jun; 162():114574. PubMed ID: 36996677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications.
    Kulkarni AR; Garai S; Janero DR; Thakur GA
    Methods Enzymol; 2017; 593():281-315. PubMed ID: 28750808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
    Grundmann M; Bender E; Schamberger J; Eitner F
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A
    Barresi E; Martini C; Da Settimo F; Greco G; Taliani S; Giacomelli C; Trincavelli ML
    Front Pharmacol; 2021; 12():652121. PubMed ID: 33841166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs.
    Dror RO; Green HF; Valant C; Borhani DW; Valcourt JR; Pan AC; Arlow DH; Canals M; Lane JR; Rahmani R; Baell JB; Sexton PM; Christopoulos A; Shaw DE
    Nature; 2013 Nov; 503(7475):295-9. PubMed ID: 24121438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPCR Allosteric Modulator Discovery.
    Wu Y; Tong J; Ding K; Zhou Q; Zhao S
    Adv Exp Med Biol; 2019; 1163():225-251. PubMed ID: 31707706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novobiocin and peptide analogs of α-factor are positive allosteric modulators of the yeast G protein-coupled receptor Ste2p.
    Rymer JK; Hauser M; Bourdon AK; Campagna SR; Naider F; Becker JM
    Biochim Biophys Acta; 2015 Apr; 1848(4):916-24. PubMed ID: 25576192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and Future Challenges in GPCR Drug Discovery.
    Topiol S
    Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologically targeting intracellular allosteric sites of GPCRs for drug discovery.
    Zhang M; Lan X; Li X; Lu S
    Drug Discov Today; 2023 Dec; 28(12):103803. PubMed ID: 37852356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.